RATIONALE: Biased processing of drug-associated stimuli is believed to be a crucial feature of addiction. Particularly, an attentional bias seems to contribute to the disorder's maintenance. Recent studies suggest differential effects for stimuli associated with the beginning (BEGIN-smoking-stimuli) or the terminal stage of the smoking ritual (END-smoking-stimuli), with the former but not the later evoking high cue-reactivity. OBJECTIVE: The current study investigated the neuronal network underlying an attentional bias to BEGIN-smoking-stimuli and END-smoking-stimuli in smokers and tested the hypothesis that the attentional bias is greater for BEGIN-smoking-stimuli. METHODS: Sixteen non-deprived smokers and 16 non-smoking controls participated in an fMRI study. Drug pictures (BEGIN-smoking-stimuli, END-smoking-stimuli) and control pictures were overlaid with geometrical figures and presented for 300 ms. Subjects had to identify picture content (identification-task) or figure orientation (distraction-task). The distraction-task was intended to demonstrate attentional bias. RESULTS: Behavioral data revealed an attentional bias to BEGIN-smoking-stimuli but not to END-smoking-stimuli in both groups. However, only smokers showed mesocorticolimbic deactivations in the distraction-task with BEGIN-smoking-stimuli. Importantly, these deactivations were significantly stronger for BEGIN- than for END-smoking-stimuli and correlated with the attentional bias score. CONCLUSIONS: Several explanations may account for missing group differences in behavioral data. Brain data suggest smokers using regulatory strategies in response to BEGIN-smoking-stimuli to prevent the elicitation of motivational responses interfering with distraction-task performance. These strategies could be reflected in the observed deactivations and might lead to a performance level in smokers that is similar to that of non-smokers.
RATIONALE: Biased processing of drug-associated stimuli is believed to be a crucial feature of addiction. Particularly, an attentional bias seems to contribute to the disorder's maintenance. Recent studies suggest differential effects for stimuli associated with the beginning (BEGIN-smoking-stimuli) or the terminal stage of the smoking ritual (END-smoking-stimuli), with the former but not the later evoking high cue-reactivity. OBJECTIVE: The current study investigated the neuronal network underlying an attentional bias to BEGIN-smoking-stimuli and END-smoking-stimuli in smokers and tested the hypothesis that the attentional bias is greater for BEGIN-smoking-stimuli. METHODS: Sixteen non-deprived smokers and 16 non-smoking controls participated in an fMRI study. Drug pictures (BEGIN-smoking-stimuli, END-smoking-stimuli) and control pictures were overlaid with geometrical figures and presented for 300 ms. Subjects had to identify picture content (identification-task) or figure orientation (distraction-task). The distraction-task was intended to demonstrate attentional bias. RESULTS: Behavioral data revealed an attentional bias to BEGIN-smoking-stimuli but not to END-smoking-stimuli in both groups. However, only smokers showed mesocorticolimbic deactivations in the distraction-task with BEGIN-smoking-stimuli. Importantly, these deactivations were significantly stronger for BEGIN- than for END-smoking-stimuli and correlated with the attentional bias score. CONCLUSIONS: Several explanations may account for missing group differences in behavioral data. Brain data suggest smokers using regulatory strategies in response to BEGIN-smoking-stimuli to prevent the elicitation of motivational responses interfering with distraction-task performance. These strategies could be reflected in the observed deactivations and might lead to a performance level in smokers that is similar to that of non-smokers.
Authors: P J Bushnell; E D Levin; R T Marrocco; M F Sarter; B J Strupp; D M Warburton Journal: Neurotoxicol Teratol Date: 2000 Jul-Aug Impact factor: 3.763
Authors: Ronald N Ehrman; Steven J Robbins; Melissa A Bromwell; Megan E Lankford; John R Monterosso; Charles P O'Brien Journal: Drug Alcohol Depend Date: 2002-07-01 Impact factor: 4.492
Authors: Nora D Volkow; Joanna S Fowler; Gene-Jack Wang; Frank Telang; Jean Logan; Millard Jayne; Yeming Ma; Kith Pradhan; Christopher Wong; James M Swanson Journal: Neuroimage Date: 2009-11-11 Impact factor: 6.556
Authors: Karen D Ersche; Edward T Bullmore; Kevin J Craig; Shaila S Shabbir; Sanja Abbott; Ulrich Müller; Cinly Ooi; John Suckling; Anna Barnes; Barbara J Sahakian; Emilio V Merlo-Pich; Trevor W Robbins Journal: Arch Gen Psychiatry Date: 2010-06
Authors: Maartje Luijten; Dick J Veltman; Robert Hester; Marion Smits; Lolke Pepplinkhuizen; Ingmar H A Franken Journal: Neuropsychopharmacology Date: 2012-08-01 Impact factor: 7.853
Authors: Bastian Stippekohl; Markus H Winkler; Bertram Walter; Sabine Kagerer; Ronald F Mucha; Paul Pauli; Dieter Vaitl; Rudolf Stark Journal: PLoS One Date: 2012-11-14 Impact factor: 3.240